Director Cutler Joel E disposed of 5,656,571 shares (SEC Form 4)

$WRBY
Ophthalmic Goods
Health Care
Get the next $WRBY alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cutler Joel E

(Last) (First) (Middle)
20 UNIVERSITY ROAD, 4TH FLOOR

(Street)
CAMBRIDGE MA 02138

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Warby Parker Inc. [ WRBY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 03/18/2025 J(1) 984,692 D $0 0 I Directly held by General Catalyst Group V, L.P.(2)(3)
Class A Common Stock 03/18/2025 J(4) 4,549,501 D $0 0 I Directly held by General Catalyst Group V Supplemental, L.P.(2)(3)
Class A Common Stock 03/18/2025 J(5) 122,378 D $0 0 I Directly held by GC Entrepreneurs Fund V, L.P.(2)(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Effective March 18, 2025, General Catalyst Group V, L.P. ("GC V"), a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 984,692 shares of Class A Common Stock of the Issuer to its general and limited partners.
2. General Catalyst Group Management Holdings GP, LLC ("GCGMH LLC") is the general partner of General Catalyst Group Management Holdings, L.P. ("GCGMH"), which is the manager of GCGMH, which is the manager of General Catalyst GP V, LLC ("GC V GPLLC"). General Catalyst Partners V, L.P. ("GC V GPLP") is the sole general partner of GC V, GC Entrepreneurs Fund V, L.P. ("E Fund V") and General Catalyst Group V Supplemental, L.P. ("GC V Supplemental"). GC V GPLLC is the sole general partner of GC V GPLP. Both GCGMH LLC and GC V GPLLC are controlled by a group of three or more individuals (the "Managing Directors"), having shared voting and dispositive control over the shares held by GC V, GC V Supplemental and E Fund V. Under the so-called "rule of three," because voting and dispositive decisions are made by a majority of both GCGMH LLC and GC V GPLLC Managing Directors,
3. (Continued from footnote 2) no one of the Managing Directors is deemed to be a beneficial owner of the Issuer's securities held by GC V, GC V Supplemental and E Fund V.
4. Effective March 18, 2025, GC V Supplemental, a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 4,549,501 shares of Class A Common Stock of the Issuer to its general and limited partners.
5. Effective March 18, 2025, E Fund V, a venture capital partnership, distributed in-kind on a pro-rata basis, without consideration, a total of 122,378 shares of Class A Common Stock of the Issuer to its general and limited partners.
/s/ Christopher McCain, Attorney-in-Fact for Joel Cutler 03/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $WRBY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$WRBY

DatePrice TargetRatingAnalyst
2/28/2025$28.00 → $30.00Outperform
Telsey Advisory Group
2/25/2025$26.00Neutral
ROTH MKM
2/5/2025$19.00 → $23.00Neutral → Sell
Citigroup
1/17/2025$23.00Outperform → In-line
Evercore ISI
11/19/2024$22.00 → $26.00Outperform
Telsey Advisory Group
11/8/2024$19.00 → $22.00Outperform
Telsey Advisory Group
11/7/2024Mkt Perform → Outperform
William Blair
10/21/2024$15.00 → $18.00Neutral → Buy
Goldman
More analyst ratings

$WRBY
Press Releases

Fastest customizable press release news feed in the world

See more
  • Target and Warby Parker Team Up to Bring Stylish, Affordable Eyewear to More Consumers

    New Warby Parker at Target shop-in-shops will offer guests designer-quality eyewear as well as contacts and eye exams Five shop-in-shops will debut in 2025 with plans to open more in the years aheadMINNEAPOLIS and NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Target Corporation (NYSE:TGT) and Warby Parker (NYSE:WRBY) are partnering to bring designer-quality, affordable eyewear to even more consumers through the retailer's newest shop-in-shop, Warby Parker at Target. Each Warby Parker at Target shop-in-shop will offer products and services — including glasses, sunglasses, contacts, e

    $TGT
    $WRBY
    Department/Specialty Retail Stores
    Consumer Discretionary
    Ophthalmic Goods
    Health Care
  • Warby Parker Announces Fourth Quarter and Full Year 2024 Results

    Q4 net revenue increased 17.8% year over year; 2024 net revenue increased 15.2% year over year Active Customers increased 7.8% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2024. "Our strong 2024 results highlight the power of Warby Parker's brand and unmatched value proposition combined with our team's high-quality execution. We delivered on our ambitious goals to accelerate revenue growth, customer growth and glasses growth, all while maintaining operational discipline and expanding p

    $TGT
    $WRBY
    Department/Specialty Retail Stores
    Consumer Discretionary
    Ophthalmic Goods
    Health Care
  • Warby Parker to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2024 will be released before market open on February 27, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 460770. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    $WRBY
    Ophthalmic Goods
    Health Care

$WRBY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$WRBY
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$WRBY
SEC Filings

See more

$WRBY
Leadership Updates

Live Leadership Updates

See more
  • Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

    $WRBY
    Ophthalmic Goods
    Health Care

$WRBY
Financials

Live finance-specific insights

See more
  • Warby Parker Announces Fourth Quarter and Full Year 2024 Results

    Q4 net revenue increased 17.8% year over year; 2024 net revenue increased 15.2% year over year Active Customers increased 7.8% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2024. "Our strong 2024 results highlight the power of Warby Parker's brand and unmatched value proposition combined with our team's high-quality execution. We delivered on our ambitious goals to accelerate revenue growth, customer growth and glasses growth, all while maintaining operational discipline and expanding p

    $TGT
    $WRBY
    Department/Specialty Retail Stores
    Consumer Discretionary
    Ophthalmic Goods
    Health Care
  • Warby Parker to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2024 will be released before market open on February 27, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 460770. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    $WRBY
    Ophthalmic Goods
    Health Care
  • Warby Parker Announces Third Quarter 2024 Results

    Net revenue increased 13.3% year over year to $192.4 million; Company raises FY outlook Active Customers increased 5.6% on a trailing 12-month basis; Average Revenue per Customer increased 7.5% Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2024. "Warby Parker's Q3 performance is a direct result of our team's commitment to making progress on our strategic initiatives, in particular expanding our marketing efforts, investing in store expansion, and enhancing our holistic vision care offering," shared Co-Founder and Co-CEO Neil Blumen

    $WRBY
    Ophthalmic Goods
    Health Care

$WRBY
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more